Photodiagnosis and Photodynamic Therapy
Volume 5, Issue 1 , Pages 29-35 , March 2008

Brain photodiagnosis (PD), fluorescence guided resection (FGR) and photodynamic therapy (PDT): Past, present and future

  • M. Sam Eljamel, MD, FRCSIr&ED(SN)

      Affiliations

    • Corresponding Author InformationTel.: +44 1382 660111x35712; fax: +44 1382 496202.
    web address

References 

  1. Tsai JC, Hsiao YY, Teng LJ, Chen CT, Kao MC. Comparative study on the ALA photodynamic effects of human glioma and meningioma cells. Lasers Surg Med. 1999;24:296–305
  2. Stummer W, Stocker S, Novotny A, et al. In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid. J Photochem Photobiol. 1998;45:160–169
  3. Sreenivasan R, Muruganandham M, Sharma M, Joshi PG, Joshi NB. Binding of monometric and oligomeric porphyrins to human glioblastoma (U-87MG) cells and their photosensitivity. Cancer Lett. 1997;120:45–51
  4. Abernathey CD, Anderson RE, Kooistra KL, Laws ER. Activity of phthalocyanine against human Glioblastoma in vitro. Neurosurgery. 1987;21:468–473
  5. Powers SK, Wlastad DL, Brown JT, Detty M, Watkins PJ. Photosensitization of human glioma cells by chalcogenapylium dyes. J Neurol Oncol. 1989;7:179–188
  6. Sharma M, Joshi PG, Joshi NB. MC540 induced photosensitization of glioma and neuroblastoma cells. Ind J Med Res. 1994;99:124–128
  7. Leach MW, Higgins RJ, Autry SA, Boggan JE, Lee SJ, Smith KM. In vitro photodynamic effects of lysyl chlorine p6; cell survival localization and ultrastructural changes. Photochem Photobiol. 1993;58:653–660
  8. Wharen RE, So S, Anderson RE, Laws ER. Hematoporphyrin derivative photocutotoxicity of human Glioblastoma in cell culture. Neurosurgery. 1986;19:495–501
  9. Lilge L, Olivo MC, Schatz SW, MaGuire JA, Wilson BC. The sensitivity of normal brain and intracranially implanted ZX2 tumor to interstitial photodynamic therapy. Br J Cancer. 1996;73:332–343
  10. Whelan HT, Schmidt MH, Segura AD, et al. The role of photodynamic therapy in posterior fossa brain tumors, a preclinical study in a canine glioma model. J Neurosurg. 1993;79:568–582
  11. Ji Y, Walstad D, Brown JT, Powers SK. Improved survival from intracavitary photodynamic therapy of rat glioma. Photochem Photobiol. 1992;46:385–390
  12. Leach MW, Higgins RJ, Boggan JE, Lee SJ, Autry S, Smith KM. Effectiveness of a lysyl chlorine p6/chlorine p6 mixture in photodynamic therapy of the subcutaneous 9L glioma in the rat. Can Res. 1992;52:1235–1239
  13. Powers SK, Beckman WC, Brown JT, Kolpack LC. Interstitial laser photochemotherapy of rhodamine 123 sensitized rat glioma. J Neurosurg. 1987;67:889–894
  14. Kostron H, Swartz MR, Miller DC, Martuza RL. The interaction of hematoporphyrin derivative, light and ionizing radiation in a rat glioma model. Cancer. 1986;57:964–970
  15. Kaye AH, Morstyn G, Ashcroft RG. Uptake and retention of hematoporphyrin derivative in an in vivo/in vitro model of cerebral glioma. Neurosurgery. 1985;17:883–890
  16. Cheng MK, McKean J, Mieke B, Tulip J, Boisvert D. Photoradiation therapy of 9L gliosarcoma in rats; hematoporphyrin derivative (type I & II) followed by laser energy. J Neuroncol. 1985;3:217–228
  17. Rounds DE, Doiron DR, Jacques DB, Shelden CH, Olson RS. Phototoxicity of brain tissue in hematoporphyrin derivative treated mice. Prog Clin Biol Res. 1984;170:613–628
  18. Boggan JE, Edwards MS, Bolger CA, Berns MW, Walter RJ. Hematoporphyrin derivative photoradiation therapy of the rat 9L gliosarcoma brain tumor model. Lasers Surg Med. 1984;4:99–105
  19. Perria C, Capuzzo T, Cavagnaro G, et al. Fast attempts at the photodynamic treatment of human gliomas. J Neurosurg Sci. 1980;24:119–129
  20. Kaye AH, Morstyn G, Brownbill D. Adjuvant high-dose photoradiation therapy in the treatment of cerebral glioma, a phase I/II study. J Neurosurg. 1987;67:500–505
  21. Kostron H, Fritsch E, Grunert V. Photodynamic therapy of malignant brain tumors; a phase I/II trial. Br J Neurosurg. 1988;2:241–248
  22. Muller P, Wilson B. Photodynamic therapy of brain tumours-postoperative field fractionation. J Photochem Photobiol. 1991;9:117–119
  23. Origitano TC, Reichman OH. Photodynamic therapy for intracranial neoplasms; development of an image-based computer assisted protocol for photodynamic therapy of intracranial neoplasms. Neurosurgery. 1993;32:587–595
  24. Kostron H, Obwegeser A, Jakober R. Photodynmaic therapy in neurosurgery, a review. J Photochem Photobiol Biol. 1996;36:157–168
  25. Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ. Fluorescence guided resection of Glioblastoma multiforme by using 5-aminolevulenic acid induced porphyrins; a prospective study in 52 consecutive patients. J Neurosurg. 2000;93:1003–1013
  26. Stylli SS, Kaye AH, MacGregor L, Howes M, Rajendra P. Photodynamic therapy of high grade glioma—long term survival. J Clin Neurosci. 2005;12:389–398
  27. Kostron H, Fiegele T, Akatuna E. Combination of FOSCAN® mediated fluorescence guided resection and photodynamic treatment as new therapeutic concept for malignant brain tumors. Med Las Appl. 2006;21:285–290
  28. Stummer W, Pitchimeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomized controlled multicentre phase III trial. Lancet Oncol. 2006;7:392–401
  29. Muller P. Photodynamic therapy in brain tumors, work in progress. In: Proceedings of the International Photodynamic Therapy Symposium. Brixen, Italy. October 2006;
  30. Eljamel M, Goodman C, Moseley H. ALA and photofrin fluorescence guided resection and repetitive PDT in glioblastomas multiforme: a single centre Phase III randomized controlled trial. Lasers Med Sci 2007;October 10:DOI 10:1007/s10103-007-0494-2.
  31. Moseley H, Mclean C, Hockaday S, Eljamel M. In vitro light distributions from intracranial PDT balloons. Photodiag Photodyn Therapy. 2007;4:213–220

PII: S1572-1000(08)00007-0

doi: 10.1016/j.pdpdt.2008.01.006

Photodiagnosis and Photodynamic Therapy
Volume 5, Issue 1 , Pages 29-35 , March 2008